ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$3.500
+$0.130 (+3.86%)
Day Range
$3.260 - $3.540
52 Week Range
$0.560 - $5.240
Volume
488.34K
Avg Volume (10D)
482.84K
Market Cap
$553.29M
Price Chart
Market Statistics
Open$3.380
Previous Close$3.370
Day High$3.540
Day Low$3.260
52 Week High$5.240
52 Week Low$0.560
Valuation
Market Cap553.29M
Shares Outstanding158.08M
Price to Book5.34
Trading Activity
Volume488.34K
Value Traded1.67M
Bid$3.500 × 5,000
Ask$3.540 × 1,000
Performance
1 Day-11.18%
5 Day-2.27%
13 Week-19.89%
52 Week302.67%
YTD-35.88%
Technical Indicators
RSI (14)53.41
50-Day SMA$3.746
200-Day SMA$2.557
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
